HomeProductsBioactive CompoundsAnti-Infective AgentsHCVGlecaprevir
Chemical structure of CAS 1365970-03-1

Glecaprevir

CAS No.1365970-03-1
MDL No.N/A
MFC38H46F4N6O9S
MW838.90
InChI KeyMLSQGNCUYAMAHD-ITNVBOSISA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1365970-03-1
Product NameGlecaprevir

Associated Conditions

chronic hepatitis C virus infection·liver disease·hepatitis C virus infection·kidney disease·chronic kidney disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection.

Antimicrobial agents and chemotherapy • Vol. 60, Issue 3 • 2015
PMID: 26711747PMC: PMC4775945DOI: 10.1128/AAC.02264-15

Hepatitis C virus NS3 inhibitors: current and future perspectives.

BioMed research international • Vol. 2013 • 2013
PMID: 24282816PMC: PMC3825274DOI: 10.1155/2013/467869

Kinetic mechanism from steady-state kinetics of the reaction catalysed by baker's-yeast glucose 6-phosphate dehydrogenase in solution and covalently attached to sepharose.

The Biochemical journal • Vol. 157, Issue 2 • 1976
PMID: 9071PMC: PMC1163864DOI: 10.1042/bj1570389

Documentation

Similar Products